TSG101 was originally defined as a tumor susceptibility gene and later characterized to be a core component of the ESCRT-I complex, and functions in the vacuolar protein sorting pathway involved in trafficking targets for lysosomal degradation [27,28]. The gene discussed is TSG101; the disease is neoplasm.